Viewing Study NCT02733159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2026-02-18 @ 1:38 AM
Study NCT ID: NCT02733159
Status: COMPLETED
Last Update Posted: 2025-02-10
First Post: 2016-03-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2
Sponsor: University of Birmingham
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Performance Status 2 View
None Pembrolizumab View
None MK-3475 View